Presentations at the 20th Annual Meet... - Advanced Prostate...

Advanced Prostate Cancer

21,011 members26,186 posts

Presentations at the 20th Annual Meeting of the Society of Urologic Oncology (SUO), Dec 04 - 06, 2019 in Washington DC.

pjoshea13 profile image
3 Replies

See link for access any of the 30 prsentations: -Patrick

urotoday.com/conference-hig...

SUO 2019 Prostate Cancer

SUO 2019: Bipolar AR Therapy

SUO 2019: Bipolar Androgen Therapy for Men with Castration Resistant Prostate Cancer

SUO 2019: Optimal Management of Metastatic Castration Sensitive Prostate Cancer

SUO 2019: PARP Inhibitors for Prostate Cancer

SUO 2019: Implementation of Standard Opioid Prescribing Schedules Following Urologic Surgeries Reduces Opioid Prescriptions Without Change in Patient Reported Outcomes

SUO 2019: Poly ADP Ribose Polymerase (PARP) Inhibitors for Prostate Cancer

SUO 2019: Transperineal Versus Transrectal Ultrasound-Guided Systematic Biopsy: Understanding the True Costs Utilizing Time-Driven Activity-Based Costing

SUO 2019: Evaluation of Biomarkers 4K Score, SelectMDx and ExoDx™, PSAD, TRUS and MRI for the Detection of High-Grade Prostate Cancer

SUO 2019: Characterization of 68GA-PSMA and 18F-Fluciclovine (Axumin®) Transporter Gene Expression in Localized Prostate Cancer

SUO 2019: My Active Surveillance Trajectory: A Literary Bibliography - Laurence Klotz

SUO 2019: Radiotherapy after Radical Prostatectomy: Effect of Timing of Post-Prostatectomy Radiation on Functional Outcomes

SUO 2019: How to Improve Uro-Oncological Surgery with Intraoperative Real-Time Multisensory Technology

SUO 2019: Heterogeneity in Policy Effect: Changes in Prostate Cancer Screening Associated with ACO Participation

SUO 2019: 2019 Richard D. Williams, MD Prostate Cancer Research Excellence Award Lecture: Prostate Cancer Screening

SUO 2019: Genomic Umbrella Neoadjuvant Study and other Biomarker Trials

SUO 2019: An Update on CALGB 90203, Radical Prostatectomy with or without Neoadjuvant Chemohormonal Therapy in Men with Clinically Localized, High-Risk Prostate Cancer, The PUNCH Study

SUO 2019: Evolving Role of Genomic Biomarkers in Localized Prostate Cancer

SUO 2019: What Can We Learn from the Breast Experience?

SUO 2019: Novel Hormone Therapies + Androgen Receptor Pathway Inhibition

SUO 2019: Organ Preservation in Urologic Cancers - Prostate Cancer

SUO 2019: Setting Up for Success in (Mostly Clinical) Research as a Young Urologic Oncologist

SUO 2019: Recovery of Sexual Function in Men Treated with Androgen Deprivation Therapy for Localized Prostate Cancer

SUO 2019: Clinically Interpretable Estimates from Statistical Models

SUO 2019: Critical Evaluation of the P-Value in Clinical Trials Reporting

SUO 2019: Systematic Review and Meta-Analysis of Trials Evaluating the Role of Adjuvant Radiation After Radical Prostatectomy for Prostate Cancer

SUO 2019: Resilience: The Art of Failing Forward

SUO 2019: Failing Forward: A Research Perspective

SUO 2019: Treatment Selection Models for Comparative Effectiveness Research

SUO 2019: No Association Between Pre-Treatment PTSD or Depression with Biochemical Recurrence Following Radical Prostatectomy Within the Veterans Affairs Health System: Results from the SEARCH Database

SUO 2019: Overview of Clinical Research Process and Clinical Trials Structure

Written by
pjoshea13 profile image
pjoshea13
To view profiles and participate in discussions please or .
Read more about...
3 Replies
Nachas613 profile image
Nachas613

Thanks

tallguy2 profile image
tallguy2

Thanks for posting this!

monte1111 profile image
monte1111

Thanks. I found some interesting content.

You may also like...

Testosterone & Castration-Resistant PCa.

metastatic prostate cancer who are treated with androgen deprivation therapy will eventually...

Why does BAT work in so few?

Bipolar Androgen Therapy (BAT), which entails cycling between androgen deprivation therapy (ADT) and

Ipatasertib+abiraterone effective in men with PTEN-loss

As genomic breakdown continues in prostate cancer metastases, PTEN, a tumor suppressor gene, and the

BAT therapy - NIH article

Efficacy and safety of bipolar androgen therapy in castration-resistant prostate cancer following...

What Are Reasons Not to Use Bipolar Androgen Therapy (BAT)?

Bipolar Androgen Therapy (BAT) is the alternation of Androgen Deprivation Therapy with high doses of